Alembic informs about board decision

10 Aug 2023 Evaluate
Alembic has informed that the Board of Directors of Alembic at its meeting held today has approved the Unaudited Financial Results of the Company for the quarter ended on 30 1h June, 2023. It enclosed the following: Consolidated Unaudited Financial Results of the Company for the quarter ended on 30th June, 2023, Standalone Unaudited Financial Results of the Company for the quarter ended on 30th June, 2023, Limited Review Report by Statutory Auditors on the Consolidated and Standalone Unaudited Financial Results; Noted resignation of Drigesh Mittal (ICSI Membership No. F8213) from the position of the Company Secretary & Compliance Officer (Key Managerial Personnel) of the Company with effective from 21st August, 2023 (after closure of business hours). The detailed disclosure in this regard is being submitted vide a separate communication; Appointed Keval Thakkar (ICSI Membership No. A39127) as the Company Secretary & Compliance Officer (Key Managerial Personnel) of the Company with effective from 1st September, 2023. The detailed disclosure in this regard is being submitted vide a separate communication. The time of commencement of the Board Meeting was 3:00 pm and the time of conclusion was 3:50 pm.

The above information is a part of company’s filings submitted to BSE.

Alembic Share Price

124.15 0.70 (0.57%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.